SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
4.470
+0.070 (1.59%)
Apr 2, 2026, 4:00 PM EDT - Market closed

SBC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
173.61205.42193.54174.16
Revenue Growth (YoY)
-15.48%6.13%11.13%-
Cost of Revenue
46.3249.3756.2459.33
Gross Profit
127.28156.05137.3114.83
Selling, General & Admin
59.857.6766.2370.65
Other Operating Expenses
-28.080.4124.06
Total Operating Expenses
59.885.7566.6494.72
Operating Income
67.4970.370.6620.12
Interest Income
0.20.020.090.47
Interest Expense
-0.16-0.03-0.05-0.03
Other Non-Operating Income (Expense)
14.543.162.883.12
Total Non-Operating Income (Expense)
14.583.152.923.56
Pretax Income
82.0773.4673.5823.68
Provision for Income Taxes
31.0226.7735.0218.12
Net Income
50.9946.6139.376.32
Minority Interest in Earnings
0.060.08-0.81-0.76
Net Income to Common
50.9946.6139.376.32
Net Income Growth
9.38%18.40%523.44%-
Shares Outstanding (Basic)
10397948
Shares Outstanding (Diluted)
10397948
Shares Change (YoY)
6.67%2.51%1084.96%-
EPS (Basic)
0.500.480.420.79
EPS (Diluted)
0.500.480.420.79
EPS Growth
4.17%14.29%-46.84%-
Shares Outstanding
102.58102.753.573.57
Free Cash Flow
22.317.1741.15-24.99
Free Cash Flow Growth
29.84%-58.26%--
Free Cash Flow Per Share
0.220.180.44-3.14
Gross Margin
73.32%75.97%70.94%65.94%
Operating Margin
38.87%34.23%36.51%11.55%
Profit Margin
29.40%22.73%19.92%3.19%
FCF Margin
12.84%8.36%21.26%-14.35%
EBITDA
70.1774.182.9126.05
EBITDA Margin
40.42%36.07%42.84%14.96%
EBIT
67.4970.370.6620.12
EBIT Margin
38.87%34.23%36.51%11.55%
Effective Tax Rate
37.80%36.44%47.59%76.55%
Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q